Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.72 USD | -2.68% | -6.90% | -27.78% |
Valuation
Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Capitalization 1 | 953.9 | 658.4 | - | - |
Enterprise Value (EV) 1 | 953.9 | 658.4 | 658.4 | 658.4 |
P/E ratio | -1.4 x | -3.47 x | -3.15 x | -3.68 x |
Yield | - | - | - | - |
Capitalization / Revenue | - | - | 529 x | 6.17 x |
EV / Revenue | - | - | 529 x | 6.17 x |
EV / EBITDA | -10,017,948 x | - | - | - |
EV / FCF | -10.7 x | -3.47 x | -3.09 x | -3.49 x |
FCF Yield | -9.38% | -28.8% | -32.4% | -28.6% |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 41,205 | 39,376 | - | - |
Reference price 2 | 23.15 | 16.72 | 16.72 | 16.72 |
Announcement Date | 21/03/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | - | - | - | 1.245 | 106.8 |
EBITDA | - | -95.22 | - | - | - |
EBIT 1 | - | -96.71 | -211.1 | -247.2 | -193.9 |
Operating Margin | - | - | - | -19,858.47% | -181.66% |
Earnings before Tax (EBT) 1 | - | -98.15 | -201 | -247.8 | -204.9 |
Net income 1 | -40.95 | -98.15 | -200.9 | -247.7 | -204.9 |
Net margin | - | - | - | -19,898.03% | -191.94% |
EPS 2 | -104.3 | -16.53 | -4.820 | -5.301 | -4.540 |
Free Cash Flow 1 | - | -89.44 | -189.9 | -213.1 | -188.5 |
FCF margin | - | - | - | -17,112.72% | -176.55% |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 01/09/23 | 21/03/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | -28.71 | -34.96 | -40.81 | -48.29 | -55.5 | -66.37 | -53.55 | -59.1 |
Operating Margin | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -35.47 | -32.08 | -35.81 | -45.92 | -53.32 | -65.58 | -53.55 | -59.1 |
Net income 1 | -35.47 | -32.08 | -35.81 | -45.92 | -53.32 | -65.58 | -53.55 | -59.1 |
Net margin | - | - | - | - | - | - | - | - |
EPS 2 | -47.37 | -1.490 | -0.8700 | -1.121 | -1.283 | -1.539 | -1.165 | -1.295 |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 13/12/23 | 21/03/24 | 14/05/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | - | -89.4 | -190 | -213 | -188 |
ROE (net income / shareholders' equity) | - | -53% | -61.3% | -83% | - |
ROA (Net income/ Total Assets) | - | -42.4% | -51.1% | -63.5% | - |
Assets 1 | - | 231.6 | 393.3 | 390.3 | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | 8.28 | 6 | 6.33 | 7 |
Capex / Sales | - | - | - | 508.7% | 6.56% |
Announcement Date | 01/09/23 | 21/03/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.78% | 658M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- CRGX Stock
- Financials CARGO Therapeutics, Inc.